Pathway to Cures Spotlight: Be Biopharma
NBDF’s Pathway to Cures is investing in cutting edge technology and new approaches to bleeding disorders therapies. Learn more about Be Biopharma, who are testing a new way of treating hemophilia B.
NBDF’s Pathway to Cures is investing in cutting edge technology and new approaches to bleeding disorders therapies. Learn more about Be Biopharma, who are testing a new way of treating hemophilia B.